logo
Select company
Select metric
$ -117.24MNet Cash Flow - Investing
VS
Market
33
Sector
15
Industry
8
History
-
$ 9.58Close
$ 1.79 - $ 11.12 52-Week Range
Ticker Information

Ticker

LXEO

Company Name

LEXEO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXEO THERAPEUTICS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LXEO - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ -117.24M
3/31/2025$ -78.28M
12/31/2024$ -94.08M
9/30/2024$ -567K
6/30/2024$ -537K
12/31/2023$ -165K
12/31/2022$ -901K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXEO THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investing stands at $ -901K.
  • Over the past 5 years, LEXEO THERAPEUTICS INC's average CF - Investing has been $ -41.68M.
  • The median CF - Investing for LEXEO THERAPEUTICS INC during this period was $ -901K
  • LEXEO THERAPEUTICS INC reached its highest CF - Investing over the past 5 years at $ -165K.
  • The lowest CF - Investing recorded by LEXEO THERAPEUTICS INC in the same timeframe $ -117.24M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

LXEO - Net Cash Flow - Investing, Last 5 years

$ -117.24M

Minimum

Jun 30, 2025

$ -165K

Maximum

Dec 31, 2023

$ -41.68M

Average

$ -901K

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M